Cumberland Pharmaceuticals Inc. (CPIX) has a MoatMap StockRank of 86/100 based on Quality (41/100), Value (51/100), and Momentum (79/100) factor scores. The current signal is STRONG BUY. Cumberland Pharmaceuticals is a micro-cap specialty pharmaceutical company. It lacks scale, has inconsistent profitability, and does not possess the robust regulatory or manufacturing moats of high-quality CDMOs.
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription products for hospital acute care and gastroenterology. The company's competitive moat is its established commercial infrastructure and a portfolio of proprietary, FDA-approved niche drugs. Cumberland operates as a focused specialty drug manufacturer with a targeted sales force in the United States.
| Price | $5.84 |
| Market Cap | $90M |
| P/E (Forward) | 41.71 |
| Price/Book | 4.04 |
| Return on Equity | -29.8% |
| Return on Invested Capital | -5.8% |
| Debt/Equity | 47.27 |
| Gross Margin | 82.9% |
| Operating Margin | -34.3% |
| Revenue Growth | -22.0% |
| Free Cash Flow | $5M |
Cumberland Pharmaceuticals Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).